About Retatrutide
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling. It is supplied as a lyophilized powder for investigations into receptor pharmacology, energy metabolism pathways, and glucose regulation mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
GIPR:GCGR co-agonism restores normal weight in obese rodents.
Recent research on Retatrutide: GIPR:GCGR co-agonism restores normal weight in obese rodents.
Read Full Study on PubMedMulti-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
Recent research on Retatrutide: Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
Read Full Study on PubMedAdditional Studies
Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.
Recent research on Retatrutide: Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.
Read on PubMedChildhood obesity and cardiac risk in youth: Emerging challenges toward 2050.
Recent research on Retatrutide: Childhood obesity and cardiac risk in youth: Emerging challenges toward 2050.
Read on PubMedNew Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication.
Recent research on Retatrutide: New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication.
Read on PubMedPharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes.
Recent research on Retatrutide: Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes.
Read on PubMedRetatrutide in type 2 diabetes mellitus and obesity: an overview.
Recent research on Retatrutide: Retatrutide in type 2 diabetes mellitus and obesity: an overview.
Read on PubMedRetatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.
Recent research on Retatrutide: Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.
Read on PubMedRelated Research
Purchase Retatrutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.